StreetInsider.com News Articles

Form 144 RECURSION PHARMACEUTICAL Filed by: Borgeson Blake

Tue, 02 Jun 2026 11:05:00 -0400

si-local-file:///var/storage/secattach/20260602/26589651.html

Form 144 RECURSION PHARMACEUTICAL Filed by: Borgeson Blake

Tue, 02 Jun 2026 11:05:00 -0400

si-local-file:///var/storage/secattach/20260602/26589651.html

Recursion to Participate in Upcoming Investor Conferences

Tue, 02 Jun 2026 08:00:00 -0400

Salt Lake City, UT, June 02, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced its participation in an upcoming investor conference:

Goldman Sachs 47th Annual Global Healthcare Conference — Tuesday, June 9, 2026

Webcasts may be found in the events section of the Recursion Investor Relations website at ir.recursion.com.
About Recursion
Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve

Recursion to Participate in Upcoming Investor Conferences

Tue, 02 Jun 2026 08:00:00 -0400

Goldman Sachs 47th Annual Global Healthcare Conference — Tuesday, June 9, 2026

Recursion to Participate in Upcoming Investor Conferences

Tue, 02 Jun 2026 08:00:00 -0400

Goldman Sachs 47th Annual Global Healthcare Conference — Tuesday, June 9, 2026

Recursion to Participate in Upcoming Investor Conferences

Tue, 02 Jun 2026 08:00:00 -0400

Goldman Sachs 47th Annual Global Healthcare Conference — Tuesday, June 9, 2026

Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules

Fri, 29 May 2026 16:30:00 -0400

Salt Lake City, UT, May 29, 2026 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced that on May 26, 2026, the Compensation Committee of Recursion's Board of Directors approved the grant of inducement restricted stock unit (RSU) awards covering 2,991,840 shares of its class A common stock in the aggregate to 33 new employees under Recursion's 2024 Inducement Equity Incentive Plan (the “2024 Plan”). Each award was granted as an inducement material to the employee's commencement of employment with Recursion, or a subsidiary of Recursion, pursuant to

Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules

Fri, 29 May 2026 16:30:00 -0400

Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules

Fri, 29 May 2026 16:30:00 -0400

Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules

Fri, 29 May 2026 16:30:00 -0400

Form 4 RECURSION PHARMACEUTICAL For: May 22 Filed by: Gibson Christopher

Wed, 27 May 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260527/26558065.html

Form 4 RECURSION PHARMACEUTICAL For: May 22 Filed by: Gibson Christopher

Wed, 27 May 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260527/26558065.html

Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher

Fri, 22 May 2026 10:14:00 -0400

si-local-file:///var/storage/secattach/20260522/26539516.html

Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher

Fri, 22 May 2026 10:14:00 -0400

si-local-file:///var/storage/secattach/20260522/26539516.html

Form 4 RECURSION PHARMACEUTICAL For: May 15 Filed by: Taylor Ben R